Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Joseph Tucker, PhD, CEO of Enveric Biosciences, Naples, FL, explains how the company aims to tackle the untreated side effects of cancer and cancer treatment, from which many patients suffer. The key avenues of research include cannabinoids for radiation dermatitis and psychedelcis for cancer-related distress.
Disclosures
Forward-Looking Statements
This video presentation contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. A discussion of these factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.